The new generation hDHODH inhibitor MEDS433 hinders the in vitro replication of SARS-CoV-2
A. Calistri, A. Luganini, V. Conciatori, C. Del Vecchio, S. Sainas, D. Boschi, M. L. Lolli, G. Gribaudo, C. Parolin
The paper identifies MEDS433, a hDHODH inhibitor, as effective against SARS-CoV-2 in vitro by blocking viral replication through hDHODH inhibition.
bioRxiv · Dec 6, 2020Microbiology